Glycoprotein VI Inhibitors (Sanofi)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGlycoprotein VI Inhibitors (Sanofi)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionPlatelet membrane glycoprotein VI inhibitors

TargetsPlatelet membrane glycoprotein VI

Therapy Area/IndicationsVascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsVascular Diseases

Other Information

ATC CodeN/A